ArticleCancer cell international2026

miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling.

Nursultan Nurdinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.